A

ATXA Therapeutics Limited

4 employees

ATXA is focusing on late-stage preclinical & clinical development of novel small molecule drugs to treat Pulmonary Arterial Hypertension.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Therapeutics
Pharmaceutical

Date founded

2015

Funding rounds raised

Total raised

$4.2M

from 2 investors over 2 rounds

A

ATXA Therapeutics Limited raised $4.2M on October 1, 2018

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

A

ATXA Therapeutics Limited raised undisclosed on July 7, 2016

Investors: Enterprise Ireland

FAQ